TPH1 and SERT were selected based upon their association with serotonin (and thus vitamin D), while TDRD6 and FLT4 were selected to provide a complete spectrum of differential gene expression and to further validate and extend our previous data of these potential IBS biomarkers [68]. The gene discussed is SLC6A4; the disease is irritable bowel syndrome.